Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 41 (10), 1094-9

Genome-wide Association Study Identifies Variants at CLU and CR1 Associated With Alzheimer's Disease

Collaborators, Affiliations

Genome-wide Association Study Identifies Variants at CLU and CR1 Associated With Alzheimer's Disease

Jean-Charles Lambert et al. Nat Genet.

Abstract

The gene encoding apolipoprotein E (APOE) on chromosome 19 is the only confirmed susceptibility locus for late-onset Alzheimer's disease. To identify other risk loci, we conducted a large genome-wide association study of 2,032 individuals from France with Alzheimer's disease (cases) and 5,328 controls. Markers outside APOE with suggestive evidence of association (P < 10(-5)) were examined in collections from Belgium, Finland, Italy and Spain totaling 3,978 Alzheimer's disease cases and 3,297 controls. Two loci gave replicated evidence of association: one within CLU (also called APOJ), encoding clusterin or apolipoprotein J, on chromosome 8 (rs11136000, OR = 0.86, 95% CI 0.81-0.90, P = 7.5 x 10(-9) for combined data) and the other within CR1, encoding the complement component (3b/4b) receptor 1, on chromosome 1 (rs6656401, OR = 1.21, 95% CI 1.14-1.29, P = 3.7 x 10(-9) for combined data). Previous biological studies support roles of CLU and CR1 in the clearance of beta amyloid (Abeta) peptide, the principal constituent of amyloid plaques, which are one of the major brain lesions of individuals with Alzheimer's disease.

Comment in

Similar articles

See all similar articles

Cited by 905 PubMed Central articles

See all "Cited by" articles

References

    1. Immunopharmacology. 2000 Aug;49(1-2):187-98 - PubMed
    1. JAMA. 1997 Oct 22-29;278(16):1349-56 - PubMed
    1. Nature. 2008 Nov 6;456(7218):18-21 - PubMed
    1. J Neurochem. 1997 Jul;69(1):388-98 - PubMed
    1. Nat Genet. 2009 Feb;41(2):192-8 - PubMed

Publication types

MeSH terms

Feedback